Business Description
![Relief Therapeutics Holding SA Relief Therapeutics Holding SA logo](https://static.gurufocus.com/logos/0C00003IIO.png?14)
Relief Therapeutics Holding SA
ISIN : CH1251125998
Compare
Compare
Traded in other countries / regions
RLF.SwitzerlandRLFTF.USARLFz.UKV6M.Germany IPO Date
2013-05-17Description
Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Its pipeline includes various drug candidates in their different stages of development such as RLF-TD011, and RLF-100, among others. It also has commercial legacy products like Cambia, Setofilm, Voltadol, and Voltfast among others. Geographically the company generates a majority of its revenue from Europe (excluding Switzerland) and the rest from North America, Switzerland, and the rest of the world.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.92 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | -0.03 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -8.18 | |||||
Beneish M-Score | -1.79 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -108 | |||||
3-Year EPS without NRI Growth Rate | 22.1 | |||||
3-Year FCF Growth Rate | 20.2 | |||||
3-Year Book Growth Rate | -20.4 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 33.75 | |||||
9-Day RSI | 41.53 | |||||
14-Day RSI | 43.82 | |||||
6-1 Month Momentum % | -33.37 | |||||
12-1 Month Momentum % | -57.17 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.65 | |||||
Quick Ratio | 2.57 | |||||
Cash Ratio | 2.11 | |||||
Days Inventory | 86.48 | |||||
Days Sales Outstanding | 70.66 | |||||
Days Payable | 338.02 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -15.6 | |||||
Shareholder Yield % | -35.02 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 71.23 | |||||
Operating Margin % | -327.83 | |||||
Net Margin % | -1627.4 | |||||
FCF Margin % | -299.32 | |||||
ROE % | -100.87 | |||||
ROA % | -75.34 | |||||
ROIC % | -15.27 | |||||
ROC (Joel Greenblatt) % | -3763.23 | |||||
ROCE % | -91.22 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.32 | |||||
PB Ratio | 0.29 | |||||
EV-to-EBIT | -0.03 | |||||
EV-to-EBITDA | -0.03 | |||||
EV-to-Forward-EBITDA | -1.09 | |||||
EV-to-Revenue | 0.55 | |||||
EV-to-Forward-Revenue | 0.43 | |||||
EV-to-FCF | -0.19 | |||||
Earnings Yield (Greenblatt) % | -3396.53 | |||||
FCF Yield % | -121.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Relief Therapeutics Holding SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil CHF) | 6.033 | ||
EPS (TTM) (CHF) | 0 | ||
Beta | 99.62 | ||
Volatility % | 22.8 | ||
14-Day RSI | 43.82 | ||
14-Day ATR (CHF) | 0.033079 | ||
20-Day SMA (CHF) | 1.1765 | ||
12-1 Month Momentum % | -57.17 | ||
52-Week Range (CHF) | 1.11 - 4.5 | ||
Shares Outstanding (Mil) | 12.54 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Relief Therapeutics Holding SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Relief Therapeutics Holding SA Stock Events
Event | Date | Price(CHF) | ||
---|---|---|---|---|
No Event Data |
Relief Therapeutics Holding SA Frequently Asked Questions
What is Relief Therapeutics Holding SA(CHIX:RLFz)'s stock price today?
The current price of CHIX:RLFz is CHF1.16. The 52 week high of CHIX:RLFz is CHF4.50 and 52 week low is CHF1.11.
When is next earnings date of Relief Therapeutics Holding SA(CHIX:RLFz)?
The next earnings date of Relief Therapeutics Holding SA(CHIX:RLFz) is 2024-09-13 Est..
Does Relief Therapeutics Holding SA(CHIX:RLFz) pay dividends? If so, how much?
Relief Therapeutics Holding SA(CHIX:RLFz) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |